NCT02003391

Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure

Prospective, Randomized, Multi-Center Study to Evaluate the Efficacy and Tolerability of DuoTrav® in Patients Previously Uncontrolled on a Beta-blocker

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 157 (actual)
• Sponsor: Alcon Research · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to demonstrate superior intraocular pressure (IOP) control with travoprost 0.004% / timolol 0.5% compared to beta-blocker monotherapy in participants with open-angle glaucoma or ocular hypertension.

Conditions

• Open Angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	Beta-blocker monotherapy	Per participant's current prescribed therapy
DRUG	Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution

Timeline

• Start date: 2013-12-01
• Primary completion: 2015-05-01
• Completion: 2015-05-01
• First posted: 2013-12-06
• Last updated: 2016-08-08
• Results posted: 2016-08-08